Angela Dempsey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angela Dempsey has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Beth Sundstrom
Department of Communication, College of Charleston, Charleston, SC 29424, USA
2 shared publications Amber Priester
Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, United States
1 shared publicationAnna Kulangara
Medical University of South Carolina, Charleston, SC, United States
1 shared publicationAnne Davis
Columbia University Medical Center, Department of Obstetrics and Gynecology, Division of Family Planning, New York, New York
1 shared publicationAnnika Van Oosbree
Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, United States
1 shared publicationAshlyn Savage
Medical University of South Carolina
1 shared publication
Latest Publications
- Open Access
- 19 June 2025
- Published by Elsevier in Contraception
- Vol. 150, 110985
Three cases of second trimester uterine evacuation in patients with partially or undiagnosed Mullerian anomalies
- 19 June 2025
- Published by Elsevier in Contraception
- Vol. 150, 110985
Open AccessThree cases of second trimester uterine evacuation in patients with partially or undiagnosed Mullerian anomalies
- Open Access
- 8 May 2025
- Published by Elsevier in Contraception
- Vol. 148, 110944
Beyond pain medication: striving toward more patient-centered placement of intrauterine devices
- 8 May 2025
- Published by Elsevier in Contraception
- Vol. 148, 110944
Open AccessBeyond pain medication: striving toward more patient-centered placement of intrauterine devices
- 8 April 2025
- Published by Elsevier in Women's Health Issues
- Vol. 35 (4) , 219-224
Promoting Improved Access to Tailored Hormonal Contraceptive Regimens for Menstrual Suppression
- 8 April 2025
- Published by Elsevier in Women's Health Issues
- Vol. 35 (4) , 219-224
Promoting Improved Access to Tailored Hormonal Contraceptive Regimens for Menstrual Suppression
- 7 July 2023
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 37, 100887
“Do you want a period?” Launching and evaluating a brief contraceptive decision-making educational intervention
- 7 July 2023
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 37, 100887
“Do you want a period?” Launching and evaluating a brief contraceptive decision-making educational intervention
- 1 October 2019
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 134 (1) , 49S
Let’s All Have Big Fun on the Bayou: Exploring Gender Differences in Year-End Faculty Evaluations
PURPOSE: Evaluate how female and male faculty score themselves on self-evaluations compared to each other and the Chairperson. BACKGROUND: For decades, women have been proportionately represented among ob/gyn residency graduates. However, male ob/gyn faculty are disproportionately represented among leadership positions and rank of professor and male salaries remain higher. Advancement and salaries are often based on evaluations. METHODS: We analyzed de-identified departmental data from 2015-2018, comparing the mean self-evaluation score (range 1-5) for female and male faculty and the difference between self and Chair rating for patient care, education and research. Continuous variables were analyzed using student t-tests. RESULTS: The mean number of female and male faculty during the study period was 16 and 15 respectively. The rank of female and male faculty were 69% and 47% assistant, 31% and 20% associate and 0% and 33% professors, respectively. Self-ratings for women and men were 4.1 vs. 4.5 (p=0.04) for patient care, 3.8 vs. 4.3 (p<0.001) for education, and 3.6 vs 3.8 (p=NS) for research. Compared to the Chair rating, the mean difference for female and male self-evaluation was similar in patient care (0.72 vs. 0.53, p=NS) and research (0.22 vs. 0.25 p=NS) but differed in education (0.9 vs. 0.5 p<0.01). DISCUSSION: Faculty self-evaluation differed between women and men; women consistently rated themselves lower, with significant discrepancies in patient care and education. Chair ratings were comparable, but were higher for females in education. The cause and impact of this gender difference in faculty evaluation merits further study.
- 1 October 2019
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 134 (1) , 49S
Let’s All Have Big Fun on the Bayou: Exploring Gender Differences in Year-End Faculty Evaluations
PURPOSE: Evaluate how female and male faculty score themselves on self-evaluations compared to each other and the Chairperson. BACKGROUND: For decades, women have been proportionately represented among ob/gyn residency graduates. However, male ob/gyn faculty are disproportionately represented among leadership positions and rank of professor and male salaries remain higher. Advancement and salaries are often based on evaluations. METHODS: We analyzed de-identified departmental data from 2015-2018, comparing the mean self-evaluation score (range 1-5) for female and male faculty and the difference between self and Chair rating for patient care, education and research. Continuous variables were analyzed using student t-tests. RESULTS: The mean number of female and male faculty during the study period was 16 and 15 respectively. The rank of female and male faculty were 69% and 47% assistant, 31% and 20% associate and 0% and 33% professors, respectively. Self-ratings for women and men were 4.1 vs. 4.5 (p=0.04) for patient care, 3.8 vs. 4.3 (p<0.001) for education, and 3.6 vs 3.8 (p=NS) for research. Compared to the Chair rating, the mean difference for female and male self-evaluation was similar in patient care (0.72 vs. 0.53, p=NS) and research (0.22 vs. 0.25 p=NS) but differed in education (0.9 vs. 0.5 p<0.01). DISCUSSION: Faculty self-evaluation differed between women and men; women consistently rated themselves lower, with significant discrepancies in patient care and education. Chair ratings were comparable, but were higher for females in education. The cause and impact of this gender difference in faculty evaluation merits further study.
- 1 October 2017
- Published by Elsevier in Contraception
- Vol. 96 (4) , 291-292
Should prenatal contraceptive counseling focus on improving patient knowledge?
- 1 October 2017
- Published by Elsevier in Contraception
- Vol. 96 (4) , 291-292
Should prenatal contraceptive counseling focus on improving patient knowledge?
- 29 September 2008
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 26 (05) , 401-410
Medical Management of Early Pregnancy Failure: How to Treat and What to Expect
Medical management is gaining acceptance as a treatment option for women with early pregnancy failure (EPF). We reviewed randomized trials comparing misoprostol for EPF with surgical (dilation and curettage) or expectant management. Overall, ~85% of women with EPF can expect complete uterine evacuation after one or two doses of 600 or 800 μg misoprostol without surgery. Medical management is safe. As with surgical therapy, serious complications are rare. Women undergoing medical management of EPF may expect moderate pain and bleeding for several days, which may persist for 2 weeks or longer. Side effects associated with misoprostol are common; however, acceptability of medical management remains high.
- 29 September 2008
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 26 (05) , 401-410
Medical Management of Early Pregnancy Failure: How to Treat and What to Expect
Medical management is gaining acceptance as a treatment option for women with early pregnancy failure (EPF). We reviewed randomized trials comparing misoprostol for EPF with surgical (dilation and curettage) or expectant management. Overall, ~85% of women with EPF can expect complete uterine evacuation after one or two doses of 600 or 800 μg misoprostol without surgery. Medical management is safe. As with surgical therapy, serious complications are rare. Women undergoing medical management of EPF may expect moderate pain and bleeding for several days, which may persist for 2 weeks or longer. Side effects associated with misoprostol are common; however, acceptability of medical management remains high.